Q4 2021 Ingredion Inc Earnings Call
Thank you ladies and gentlemen, thank you for standing by and walk through the Q4 2021 ingredient incorporated earnings call. At this time all participants are in a listen only mode. After the speaker's presentation there'll be a question and answer session to ask a question during the session on the depressed star one on your telephone if you require any further assistance. Please press star zero I would now like to turn.
The call over to your host Jason.
VP of corporate Finance you may begin.
Good morning, and welcome to ingredients fourth quarter and full year 2021 earnings call I'm, Jason <unk>, Vice President of corporate Finance and interim Vice President of Investor Relations on today's call are Jim <unk>, our president and CEO and Jim Gray, our executive Vice President and Chief financial.
Officer.
We issued our results today in a press release that can be found on our website ingredient dot com in the investors section. The slides accompanying this presentation can also be found on the website and were posted today for your convenience.
As a reminder, our comments within this presentation may contain forward looking statements. These statements are subject to various risks and uncertainties and include expectations and assumptions regarding the company's future operations and financial performance, including the impact of the COVID-19 pandemic.
Actual results could differ materially from those estimated in the forward looking statements and ingredient and assumes no obligation to update them in the future as or if.
Circumstances change.
Additional information concerning factors that could cause actual results to differ materially from those discussed during today's conference call or in this morning's press release can be found in the company's most recently filed annual report on Form 10-K , and subsequent reports on forms 10-Q and 8-K.
During this call. We also refer to certain non-GAAP financial measures, including adjusted earnings per share adjusted operating income and adjusted effective tax rate, which are reconciled to U S. GAAP measures and note to non-GAAP information included in our press release and in today's presentation appendix.
Now I'm pleased to turn the call over to Jim Sally.
Thank you, Jason and good morning, everyone.
For the full year, we delivered very strong top line performance with 15% net sales growth.
This reflected well managed sales execution by our pricing centers of excellence to manage price mix and address higher input costs, while we responded to strong customer demand.
As a result full year adjusted operating income grew 4% versus the prior year.
Now I'd like to highlight a few of our sales achievements.
For the full year, we grew net sales by double digits across all four regions by actively managing the terms of our customer contracts.
Including the pass through of higher corn and input costs.
As Youll see on the next slide this applies to not only our specialty ingredients, but also our core sweetener and starch portfolio.
Our stable cash generating core sweeteners and starches are used in a broad range of applications that saw strong demand growth in 2021.
For example, industrial starches used in paper, making and corrugated saw increased demand related to economic recovery.
In addition, pharmaceutical grades of dextrose, and starches experienced strong demand related to health care applications.
As a result net sales of these <unk>.
Other core products grew 14% versus the prior year.
In line with our strategy, we reduced the overall percentage of high fructose corn syrup sales in our portfolio from 12% to 10% as a result of our announced joint venture in Argentina.
Now turning to specialties net sales.
Specialty net sales grew strongly in each of our four regions last year and now represent 33% of global net sales.
Asia Pacific led our specialties growth driven by our sugar reduction growth platform with pure circle performing exceptionally well.
Tapioca and rice based starch texture risers also contributed to the strong performance in the region.
In EMEA, we also delivered excellent specialties growth with food systems contributions from K Tec and strong starch based texture riser demand.
South America, and North America benefited from strong foodservice demand and the pass through of higher corn and freight costs.
Now I'd like to comment on the global supply chain environment.
The global supply chain constraints, we discussed during our last earnings call, which were driven by reduced ocean container availability rail congestion truck driver shortages and the continuing impacts of the pandemic.
Intensified in the fourth quarter with the emergence of the Omicron Covid variance.
As a result, we experienced higher than expected supply chain costs in the quarter as we prioritize service and switched from lower cost to higher cost modes of transport as necessary to meet customer commitments.
We foresee these exceptional circumstances, we experienced in the fourth quarter steadily improving throughout the first quarter of this year.
Additionally, the contracted pricing actions that took effect at the beginning of 2022.
We'll address the most recent increase in input cost inflation that we experienced in the fourth quarter.
Moving on to our strategic pillars.
This year and during the quarter, we continued to execute on key initiatives to advance each of our strategic pillars.
As discussed previously global specialties net sales grew nearly 17% in 2021.
Driven by increases across all of our growth platforms.
Pure circle continues to perform very well and finished the year with positive operating income in the fourth quarter.
Moving to commercial excellence, our sales teams around the world finished the year upbeat as they continue to drive topline momentum and expand our new project and product pipelines with customers.
We successfully completed our three year cost smart program, delivering $170 million of accumulative savings, beating our original $125 million target by 36%.
We will now carry forward the momentum and learnings as part of our rebranded strategic pillar.
Cost competitiveness to continue to drive efficiencies across our business and reinvent the way we work.
All of this progress continues to be underpinned by our purpose and values driven growth culture.
We continue to make excellent strides and I will comment later on recent accomplishments and recognitions, we received in a number of areas.
Now, let me turn to a few specific specialties highlights starting with sugar reduction.
Pure circle finished the year with net sales up over 60% versus 2000, Twenty's results and continues to be a catalyst for growth in our sugar reduction and specialty sweeteners platform.
Notably we concluded the fourth quarter with positive operating income and.
And where cash and EPS accretive.
This has been a wonderful turnaround story.
In its first full year under ingredient ownership with excellent execution against the integration plan.
A reinvigorated customer base.
And a strengthened R&D pipeline.
We expect continued strong double digit growth from our sugar reduction and specialty sweeteners growth platform in 2022.
In plant based proteins, we continue to be bullish on the many opportunities ahead.
Despite the ups and downs in plant based food demand during the pandemic. The plant based protein category overall continues to grow double digits and this growth is expected to continue well into the future.
Our existing customer pipeline remains robust across many food categories, such as alternative dairy alternative meat.
Protein fortified bakery snacks and supplements.
Our 2021 net sales doubled off of a modest space.
However, our production volume ramp up has been slower than expected AD South Sioux city, as we optimize quality and yield to maximize batch sizes and extend uptime.
The team has made excellent progress, though in recent months and we are building inventory of high quality food grade product in anticipation of accelerated sales development throughout 2022.
In Vanscoy, our startup was impacted by Covid related labor shortages and equipment delays as we executed on our transition from pet food applications to consumer food products.
Today, our protein flower and specialty concentrates production lines are performing exceptionally well and sales development is accelerating.
The slower growth slower South city production ramp up vanscoy delays and higher P costs due to the drought in western Canada drove higher than expected startup costs resulted resulting in an operating loss of approximately $40 million in.
In 2021.
Going forward, we remain optimistic in the long term growth prospects for this exciting product category and expect year over year operating losses.
To decrease by approximately $10 million in 2022, and we expect to reach breakeven by late 2023.
We are actively managing yellow pea costs and are confident we've secured our yellow pea requirements for 2022.
And now let me hand, it over to Jim Gray for the financial review.
Thank you, Jim and good morning to everyone.
Starting first with our Q4 regional performance North America net sales were up 13% when compared to the same period in 2020.
North America operating income was $84 million down 35% versus the prior year.
Most of this decrease year over year was previously anticipated since we expected higher corn costs and higher energy and supply costs.
As Jim alluded to we also incurred higher cost to move products.
Some of these were expected and pass through to customers, but a portion was unexpected due to disruptions in outages in our preferred transportation lanes.
In response, our team assess the best way to serve our customers.
And purposefully opted for a higher cost and more expedient delivery solution when appropriate.
Finally, our cost absorption related to the production ramp up of our plant based protein facilities was higher year over year.
Okay.
South American net sales were down 7% versus prior year.
The decrease was primarily driven by the contribution of our Argentina operations to the <unk> joint venture in the third quarter.
Partially offset by higher pricing mix.
Absent foreign exchange sales were down 4%.
Excluding Argentina net sales would have been up 18% versus prior year.
South America operating income was $30 million down 32%.
Two thirds of the decrease was driven by onetime impacts.
First lapping of an indirect sales tax benefit in Brazil.
And second the contribution of Argentina to the <unk> JV.
The combined impact of these items represent $9 million of op income decrease.
The remainder was due to higher net corn and input costs in Brazil.
Excluding foreign exchange impacts adjusted operating income was down 29% in the quarter.
Moving to Asia Pacific net sales were up 17% in the quarter.
The increase was driven by higher volumes across the region, including pure circle.
And by favorable price mix, partially offset by negative five points of foreign currency impact.
Asia Pacific operating income was $17 million down 15% versus prior year.
As higher raw material and utility costs outpaced price mix improvement primarily in Korea.
During the quarter pure circle reported positive operating income for the last three months of the year.
In EMEA net sales increased 15% for the quarter.
The increase was due to higher volumes from K Tec as well as favorable price mix.
Absent foreign exchange sales were up 19%.
EMEA operating income was $20 million down 31% for the quarter.
The decrease was driven by higher manufacturing costs, primarily energy costs in Pakistan.
That more than offset higher volumes and favorable price mix.
Moving to our income statement net sales of $1 $755 million were up 10% for the quarter versus prior year.
Gross profit dollars were lower year over year, while gross margin was 16, 5% down over 500 basis points due to higher corn and input cost inflation.
Three quarters of the margin decrease was driven by North America North.
North America's gross margin change, which was down over 600 basis points.
Reported operating income was $86 million and adjusted operating income was $113 million.
Reported operating income was lower than adjusted operating income primarily due to restructuring costs related to customer.
Our fourth quarter reported earnings per share was <unk> 99, and adjusted earnings per share was $1 nine sets.
Turning to our Q4 net sales bridge strong price mix of $182 million was largely attributable to the pass through of higher corn costs.
The sales volume increase of $4 million was driven by volume increases in pure circle and the addition of the <unk> acquisition.
Partially offset by the impact of the contribution of our Argentina operations to the <unk> joint venture.
For the quarter reported operating income decreased $77 million, while adjusted operating income decreased $73 million.
The decrease in reported operating income versus adjusted operating income is primarily due to restructuring costs related to cost smart.
Corporate costs for the company were up for the quarter versus last year, driven by investments in global capabilities at centers of excellence.
Turning to our earnings bridge on the left side of the page you can see the reconciliation from reported to adjusted earnings per share.
On the right side operationally, we saw a decrease of <unk> 78 per share for the quarter.
The decrease was driven by operating margin decline of 90.
An unfavorable foreign exchange of three <unk>.
Partially offset by higher volumes of <unk> and other income of <unk> <unk> per share.
Moving to our non operational items, we saw an increase of <unk> 12 per share for the quarter.
Primarily driven by lower financing costs of <unk> <unk> per share and the impact of a lower adjusted effective tax rate of <unk> <unk> per share.
For the full year the company delivered net sales of $6.894 billion up 15% versus prior year.
Gross profit margin was 19, 3% down 190 basis points.
Full year reported operating income was $310 million and adjusted operating income was $685 million.
Reported operating income was lower than adjusted operating income.
Due to the <unk> joint venture related net asset impairments and restructuring costs related to cost smart.
Partially offset by the income related to the favorable decision for certain Brazilian indirect taxes.
Our full year reported earnings per share was $1 73.
And adjusted earnings per share was $6 67.
Yes.
Turning to our net sales bridge you can see that all revenue drivers contributed to growth.
Favorable price mix of $614 million was largely attributable to the pass through of higher corn costs in North America and South America.
Sales volume increase of $265 million was driven by higher volumes in Asia Pacific North America, and EMEA, including incremental sales year over year of $90 million from pure circle at $35 million from K Tec.
These increases were partially offset by a $65 million decrease in South America, resulting from the contribution of Argentina to the <unk> joint venture for the last five months of 2021.
In North America net.
Net sales were up 13% versus prior year, driven by favorable price mix.
South American net sales were up 15% driven by a 26% 26% increase in price mix in Brazil and Colombia.
Partially offset by the volume impact of the <unk> joint venture and 3% of foreign exchange weakness.
In Asia Pacific net sales were up 23% driven by higher volumes, primarily from pure circle and other favorable price mix.
EMEA net sales were up 19% driven by higher volumes in Europe , including K Tech sales for nine months of the year as well as favorable price mix in Pakistan.
<unk> contributed five points of net sales growth for the year.
As Jim mentioned, we are concluding our cost smart program with accumulative savings exceeding $170 million, beating our original target by 36%.
Cost smart was a global effort that touched every function in the organization.
Our objectives were to re imagine how we operate to improve effectiveness and efficiency and reinvest a portion of the savings we achieved to support future growth.
We delivered these significant savings by rationalizing production assets to optimize our manufacturing network expanding global shared services to all regions redesigning, our global human resources support and creating global operation centers of excellence.
We carry this momentum into cost competitiveness our.
<unk> initiatives to continuously improve our cost to serve.
For our full year operating income bridge reported operating income decreased $272 million, while adjusted operating income increased $26 million versus prior year.
The decrease in full year reported operating income versus adjusted operating income is primarily due to the $340 million net asset impairment charge related to the <unk> joint venture in Argentina.
Operating income was up in South America, Asia Pacific and EMEA.
Operating income was flat in North America, including approximately $40 million of ramp up costs associated with our plant based protein facilities.
Full year corporate cost for the company were up versus last year, driven by investments in global capabilities and centers of excellence.
Turning to our full year earnings bridge on the left side of the page we show the reconciliation from reported to adjusted.
On the right side operationally, we saw an increase of 29 per share for the full year.
The increase was driven by higher volumes at <unk> 53.
Other income of 13 and foreign exchange of seven <unk>.
Partially offset by 44 per share of margin decrease.
Moving to our non operational items, we saw an increase of <unk> 15 per share year to date.
Primarily driven by lower adjusted effective tax rate of <unk> 14 per share.
Moving to cash flow full year cash provided by operations was $392 million.
Cash provided by operations decreased versus prior year, driven by higher working capital usage.
Working capital balances were impacted by the increase in net sales.
Higher corn costs reflected in inventory values and higher input costs reflected in accounts payable balances.
Capital.
<unk> were $300 million.
Down $40 million from the prior year period due to the timing of spend.
We were in line with our expectations for new capital commitments in 2021.
During the year, we paid $172 million of dividends to ingredient shareholders and repurchased $68 million of outstanding shares.
Turning to our expectations for 2022.
Our full year 2022 reported an adjusted EPS range to $6 85 to $7 45.
This excludes the impact of acquisition related integration and restructuring costs as well as any potential impairment costs.
We expect net sales to be up high single digits to low double digits, driven by strong price mix the pass through of higher corn costs and volume growth.
We expect full year reported and adjusted operating income to be up 7% to 9% versus last year.
2022 financing costs are expected to be in the range of 72 million to $77 million.
Our adjusted effective annual tax rate is expected to be between 27, and 28, 5% which assumes.
Unfavorable impact due to changing U S tax rules.
Cash flow from operations.
As expected to be in the range of $600 million to $680 million we.
We expect modest investment into working capital as net sales growth.
Capital investment commitments are expected to be between 303 hundred $35 million.
Of which nearly $100 million will be invested to drive specialty growth.
We expect total diluted weighted average shares outstanding to be in the range of 67, five to $68 5 million for the year.
In terms of our regional outlook North America net sales are expected to be up 10% to 15%.
Operating income is expected to be up high single digits to low double digits, driven by higher volumes and favorable price mix.
And increasing plant based protein sales.
For South America.
When we compare the 2021 segment results.
Our expected results for 2022.
We would anticipate net sales to be down mid single digits and operating income to be down lower single digits.
Which reflects the contribution of Argentina to the <unk> joint venture.
In Asia Pacific, We anticipate net sales to be up 10% to 15% versus the prior year.
Expect operating income to be up high single digits, driven by higher volumes.
For EMEA, we expect net sales to be up 10% to 15% and operating income to be up low single digits, driven by higher volumes, which will largely be offset by higher costs.
For first quarter 2022.
We expect operating income to be down high single digits to low double digits versus prior year.
Our outlook for the quarter recognizes in South America that we have an approximate $7 million lap from Argentina's contributions in 2021.
Furthermore, we anticipate the layout of corn cost and co product values will present, a timing lag for margin recovery in Brazil.
Leah and Pakistan.
That concludes my comments and I'll hand, it back to Jim.
Thanks, Jim.
As I mentioned earlier, our purpose and values driven growth culture underpins all that we do we.
We were once again honored to be named to Fortune magazines list of the world's most admired companies for the 13th consecutive year.
In addition, as we continue to advance our diversity equity and inclusion agenda with a culture, where everyone belongs. We're proud to have been included on Bloomberg's gender equality index for the fifth consecutive year.
We also achieved a near perfect score on the human rights campaign Foundation's corporate equality index for the second year in a row.
In terms of sustainability.
System with our commitments outlined in our 2030, all life plan, we made significant progress towards our goal to be 100% sustainably sourced by 2025 for our six priority crops.
<unk>, 32%.
Which surpassed our 2021 target.
As an example of sustainable sourcing we advanced our regenerative agriculture program through the soil and water outcomes fund by partnering with Pepsico and nutrient to incentivize growers to choose more sustainable practices for corn grown in Illinois.
As part of this program, we shared the cost of direct payments to farmers to transition to more sustainable planting practices.
Our pilot program enrolled over 20000 acres and reduced cotwo emissions by $14 5000 metric tons.
And now I'd like to close with a few summary comments.
The second year of the pandemic was every bit as challenging as the first year, but in different ways.
What remained constant though.
It was the way our teams continue to persevere and display agility to meet strong customer demand and deliver another year of significant growth.
We overcame nearly $900 million of input cost inflation success.
<unk> successfully integrated two acquisitions.
<unk> entered into two strategic joint ventures, and continue to invest almost $100 million of capital inorganic specialty growth.
All of these achievements would not have been possible without the dedication of our talented employees worldwide.
Their efforts continue to position us well to create long term shareholder value.
And now let's open the call for questions.
Ladies and gentlemen, if you have a question or comment at this time. Please press. The Star then the one key on your Touchtone telephone. If your question has been answered you question yourself from the queue. Please press the pound key.
First question comes from Ken Zaslow with bank of Montreal.
Hey, good morning, guys. Good morning, Good morning, Ken Hey, Ken.
Two questions one is when I think about.
The cadence of the year can you talk about the difference between the first half and the second half.
And how that sets you up for the long term goal and then the more important question that I have as you said, our long term growth goal of 6% to 9% over the long term 2021, with 4%, 2022% is going to be in that 7% to 9% EBIT. So how do you make that up or do you think that your goal for <unk>.
To 9% EBITDA growth over the long term to get to 2024 numbers was too aggressive or how do you make that up.
Alright, So let me ask Jim to take the phasing question first yes sure.
And to everybody.
As we looked at 2021, the first half simply.
The cost of corn was going up we had hedged and we benefited from some co product values, which I think helped boost the first half margins in 2021 as we got into the second half of 2021 and as we have discussed with you and others was that we knew that we were going to be more exposed to.
To the to the.
Corn that was staying elevated as well as we had left some of that open so that impacted us and some in Q3 and mostly in Q4 and.
And Thats reflected I think in the Q4 year over year.
Now as we go forward and primarily in North America.
We're within our U S can business.
A little bit less than half of our contracts are flat priced we're now pricing in the change in the cost of the corn to those customers and so what youll see in 2022 is while that pricing went into effect and we still have elevated gross corn, we just have a lap of the co product value benefit and the <unk>.
First half of 2021 as we get into the second half of 2022, we really should see the pricing stick the corn.
We will still remain there and we should see a lot of margin expansion in the second half.
Okay, and then regarding the second question, Ken regarding the long term profit outlook.
Mid high single digits and the last last year and then this year I think it depends on where we finish in 2022 first of all from a standpoint of.
Whether we finished at the high end of the guidance or.
We're not but.
I would remind everybody about the significant.
Growth investments that we have made and the promise that they still hold as it relates to the investments. We've made in China. For example, which is the largest specialty food starch market in the world and that investment commissioning.
In the second half of this year the investments in plant based proteins, where we still are very bullish in regards to the commercial prospects for that.
The investments that we are making in pure circle to continue to grow more differentiated stevia products and the momentum that we have in that business.
The investments we've made in rice the investments we've made in tapioca all of those.
Bode very very well and then the other thing is.
The core business continues to provide an engine of cash for the business, but this past year the core.
Sweetener and starch business did grow 14%.
And.
There are dynamics occurring in that segment.
Segment of overall.
Core business that.
Also could lead to more stability than we have seen in years prior and I think the combination of all of that I think makes us still feel very good.
I'd say, we are going to obviously expand upon that Ken from a standpoint of more outlook at Cagny. So.
We will be able to engage with you and give you even more color on that at Cagny.
Okay.
How much of the.
In Q in fourth quarter of 2021, and then the first quarter two of 2022.
Would likely not recur in 2023 2024 and is that a component of maybe the reason that you could actually get to your long term growth alright, great and I'll leave it there.
Yes, I mean, that's obviously a key question as it relates to what happened in quarter, four and how do we view that.
What I will say is that.
Right.
Portion a portion of the impact is already being priced through in <unk>.
Quarter, one of this year.
And if I had to just maybe.
To answer your question very comprehensively.
If you reflect again on the fact that a little less than half of our revenue on fixed price contracts in U S. Canada.
Is is fixed priced and we knew going into the quarter.
We had higher net corn costs, and the chemical and energy costs were going to be higher but to a certain degree higher.
And that was all implied in our guidance what was unanticipated in the quarter.
Was the emergence of the omicron variant, which.
The news broke on that literally in the weeks after our earnings call in November and we experienced again.
Incremental costs associated with that.
And the majority of the impact that we experienced.
Was in December and December month, and so.
The ability then to price through in quarter one.
A portion of that impact.
Is already happening and will flow through in quarter one.
Ken.
To summarize, though as well in our add on to what Jim et cetera, as we experienced those unexpected costs.
Those are due to where you had a preferred carrier in that particular truck driver truck wasn't available. So you buy on spot for that particular load you get a pretty significant rate increase on that as you don't have omicron you don't have labor shortages and you have to I think a normal person would have to assume.
<unk> that supply chains returned to what we've seen historically as our expectation for on time deliveries.
At rates that are more reflective of a balanced either drive end market or an ocean freight market. So a lot of the costs that we actually occurred I do think are transitory and would not be reflected in 2023.
Alright I appreciate it.
Our next question comes from Ben Theurer with Barclays.
Perfect Good morning, Jim and Jim So actually to follow up on what you've just said around the supply chain and the cost throughput than what you've been seeing as well on on pricing into <unk>.
How difficult or easy is it to pass on these short term cost headwinds that just came up on the logistics side to your customers and is that something you would also assume to at least take a bit or shall we expect that this is more of a short term you pass that through.
It gives us a little bit of a bump into into topline, but ultimately it's not something to stick throughout the year and we should just think about the cost easing the cost pressure easing over time to be the most relevant driver of operating income growth and not so much of a pricing you've got through at the very beginning.
Yes.
How about if I sure you take a shot at it.
As color commentary thanks.
To go back I would look at Q4 and say that within Q4 in total we probably had about $20 million of unexpected costs.
Half of that was related to I'm going to call transportation and transportation preferred transportation lanes, and not having availability of the equipment or the provider the driver of the rail available to us and yet you still have a customer commitment and the foods.
Supply chain, so the supply chain team needs to make a decision that day that morning.
And they have other available avenues. So if they have to go to spot truck.
Or if there.
Relying on rail and all of a sudden our intermodal is going to be challenged than we're moving from rail to truck.
And so those are those are temporary decisions, we're going to incur the cost and that cost is going to hit the P&L now when we go back to customers.
Evidence of the customer.
Dry van rate to the customer then we can negotiate with that customer, but otherwise that's going to be costs that we incur and it's in the service of a commitment to our customers and we're maintaining those customer franchises in those relationships.
And in addition, and it's something that we talked about on the last call is.
When you have.
A more lengthy supply chain associated with say tapioca products coming in from Thailand, and you have a customer with a new product launch we did make some decisions to air freight product and for example, as well, but in all of those cases as Jim saying to answer your question, we work with our customers and our passing through those price increases.
And about Jim you would say.
Half of 'twenty was rate related and half to more than half is already being priced through in quarter. One. So if that helps answer your question very specifically been gift, yes that helps very much and then my second question is just about the.
You've laid out nicely the <unk>.
Delays in what's been.
Opening on the south.
So and the impact obviously that with.
Double the amount of initially expected and you still expect some impact from 2022.
What's been driving those delays is it is it the demand thing.
Volume ramp up or is it just operational things to actually get it established so just to understand a little bit better what's been behind the drivers of the impact in 2021, and what you expect to be better in 2022, but still not good enough to make it to breakeven.
Yes, So let me break down our plant based protein challenge in the three most relevant issues.
The one and the largest is south Sioux City, and that's where we would be producing or are producing the pea protein isolate and that's where we had a slower production ramp up again, as we optimize quality and yield.
To get in sync with maximizing batch sizes and the extended uptime. So we want to build food great inventory the plant is <unk>.
Commercially complete.
We have food grade certification.
And we are in the process of building inventories of food grade product to match.
What would be the.
Required demand based on the average volume, we anticipate per customer and to get that in sync.
Take some some time, so having the plants being able to produce consistently.
Food grade quality to build sufficient inventory such that with all of the relationships that we have and discussions with customers to get a good match, where the commercial organization in the manufacturing and ops organization feel.
We're ready to go so the good news is that our team has made excellent progress in South Sioux City over the last two months, we are steadily building high quality food grade inventory in anticipation of accelerated sales development through 2022 that again was the most significant.
Impact the second issue is related to.
Just a slower startup for our flower and concentrates facility in Vanscoy, Saskatchewan and really that was related to COVID-19 related labor shortages and delays in equipment deliveries some of that equipment was coming in from Europe , just some delays there and a very tight labor market in that particular part of Canada.
That's for the most part all behind US our specialty concentrates production lines commissioned.
In September and we started.
Carrying the cost of that in the fourth quarter today that protein flower in concentrate production is performing exceptionally well and our sales are increasing and lastly, the third issue just relates to <unk> costs due to the drought in Western Canada, and we have secured RP supply well into 2022 and.
That's all reflected in the operating income expectations for plant based proteins in 2022, hopefully that gives.
It gives you a kind of a complete picture of.
The situation in that in that particular space.
That was good thank you very much.
Thank you.
Next question comes from Adam Samuelson with Goldman Sachs.
Yes, Thank you and good morning, everyone.
Adam Adam busy morning, Hi, good morning.
So I guess my first question.
It's kind of a.
Thinking about 2000 2021.
You see a very inflationary environment.
Talked about it in the prepared remarks, I know you highlighted we've completed and exceeded our initial targets on cost smart.
And productivity I guess I'd look back in <unk>.
Shifting you exceeded those targets, but EBIT in 'twenty, one ends up being lower than where it was in 2018.
A couple of years ago, and so is the main cost Smart program now is complete how do we think about productivity.
Moving forward.
Particularly in the context that this becomes even more urgent kind of problem.
Problem in an inflationary environment.
Yeah. So.
Smart as you said served us extremely well.
<unk>.
It did it did deliver.
Beyond our initial expectations remember, we raised the target for that twice for 125 to $1 59 to $1 70 and hit the 170 target.
We are transitioning cost smart, which was one of our four strategic pillars to cost competitiveness, so cost and efficiencies is not in any way being de emphasized now that that intensified program over three years is a sunsetting, it's transitioning into cost competitiveness.
And one of the things in relationship to what could be an upside for example in 2022 relates to that initiative.
Delivering very strongly so we have a number of.
Items for operational efficiency and to set what.
To offset inflation and we're embracing something called net structural savings, which are global VP of operations is driving very very hard and we feel very confident in those programs and that represents again one of those upsides to the upper upper part of our range for 2022, so I want to make sure that no.
One.
Misinterprets that the conclusion of the cost smart say intensified three year program in any way would reduce our focus on cost. It's just being rebrand it to cost competitiveness, which is all about more of a cultural.
Embracing of continuous improvement in the organization.
Alright, that's helpful and then maybe.
Kind of.
Touch on all of it it's a pretty wide guidance range for the full year.
Not that uncommon for you guys, but.
Can you help us think about kind of how we frame what drives you to the low end versus the high end of the range in terms of volumes in terms of kind of.
<unk> versus cost inflation.
Mix, just help us think about kind of the world and a key pivot points at the high and low end.
Sure Jim is going to take that Hey, Adam I think with regard to the upsides I think.
First if inflation is less than what we've assumed.
You can see ocean freight rates coming back down.
Oil is pretty elevated that has a secondary impact into our camp costs supply costs diesel et cetera.
But inflation could be less than what we've assumed generally we've tried to benchmark.
<unk> here and kind of the late part of 2020 once in November December .
Additionally, you could see a strong return to foodservice.
Sure.
<unk>, Europe , and <unk> as well as in maybe Latam.
In Mexico, and South America, we really do think that as the.
As consumers come out and return to somewhat of a.
Our normal balance of behavior between eating out and eating at home.
We're pretty well positioned with some of our specialty ingredients to benefit from that demand take up.
I would say that within the U S.
Foodservice traffic was a bit stretched and maybe what I would say October November sort of bounce back a bit in December .
And so I just think that we still have some some potentially some residual upside on volumes out of Europe , and Latam and then third and Jim alluded to this and it's within cost competitiveness, we have many efficiency efforts and continuous improvement.
Underway that can catch up and that can surpass the inflation. So those are all upsides I think our downside is really looking at corn costs globally.
That could move higher or not.
To remind you of the Ukraine is the third largest exporter.
Corn in the marketplace.
I think any disruptions there could further even just pressure futures on corn costs, and and that doesn't really impact us as much in the U S or in Mexico, where we're largely hedged and buy domestically, but it does impact us in some of our other other countries.
And then I think finally on the downside I think it is prudent to say well there could be some additional or COVID-19 variant or there could be specific omicron breakouts throughout parts of Asia Pac.
Which couldnt.
<unk> ports in congested ports and that obviously causes some disruption so really kind of thinking about those tours are probably our largest downsides, yes, I think the low end of the guidance. We discussed it we debated it and with the fact that again on the quarter three earnings call No one knew of the omicron variant.
And the fact that we experienced that to the degree we did in quarter four and just with the unknowns around that we're saying, it's probably prudent to.
Taking into account there could be some other impact from the from the pandemic going forward Thats hopefully helps you with how we framed the guidance.
Alright, very helpful. I'll pass it on thanks, so much.
Our next.
Comes from Robert Moskow with credit Suisse.
Hey, Rod.
I had a question about the supply chain disruption cost that you're incurring.
You say that youre going to recapture some of it in the first quarter.
But are these disruptions ongoing like Orange you still.
Relying on the spot markets and rerouting volume.
I didn't see that as part of your guide for first quarter profit pressure.
Are you, saying that we're past that now and youre, not and you're back to your normal routes or not.
Yes, I don't think we would say that we're past it I would say that January it's continued and it's getting better in.
In the third week and fourth week of January and as we head here as we are in February and talking to our teams the situation is absolutely getting better.
As we as we enter February so, but the first three weeks of January it was still very intense.
Okay. So your guidance for profit down high single digit to low double digit you mentioned the layout of corn costs, you mentioned, the laptop, Argentina, but you didn't mention higher supply chain costs.
Is that.
But your cost will be higher and you've incorporated that just for a month of that.
Corporate and also for February .
We didn't obviously.
I'd really I think towards North America in the first quarter generally in North America I think we are seeing.
Relatively flat year over year right. So while we have some additional costs. Some costs that are carried in but we also have pricing and we're also catching up on the pricing pass through to the extent that we can win with customers.
Okay.
But you have your toughest comparison in first quarter North America profit.
And you are still coming in flat.
Yes, and Thats look obviously, we had.
So we had some benefit last year from <unk>.
Where we had hedged corn and the rise in the co product values.
Now this year as we go and we have higher volumes, we are going to heavily have higher pricing into customers, which was reflecting the corn cost inflation throughout 2021.
And we're also then managing through the expectation on inflation, whether it be afraid or some of our input costs.
But thats reflected and we're trying to put that into our pricing and recapturing the full before the full cost inflation that we witnessed last year.
And I think I got I actually second quarter's tougher than the first but.
That's right that's right.
A follow up for Jim Valley I.
I think you mentioned that demand for plant based proteins has been I think you mentioned volatile in year two of the pandemic can.
Can you give me a little more specifics on what you mean by that.
And also maybe a little more color on the pipeline that you have.
And when it kicks in.
What I was referring to Rob is with.
Many of the things that we read about alternative meats plant based meats.
And the.
Impact of the pandemic, the omicron variant et cetera.
On foodservice.
Consumption.
So overall that was what I was referring to but as it relates to how do we then feel about the growth prospects for plant based proteins.
Our offerings are around.
Different consumer product categories, not just alternative meat again, its alternative dairy snacks bakery.
And in the plant based ingredient portfolio, we're focused on.
Delivering attributes that would appeal to all of those categories like clean taste functionality affordability nutrition.
And we just feel very positive about.
The go forward.
When we see for example, the challenges that beyond and others have experienced to deliver through the pandemic with retail shifts.
They continue though to invest in innovation and they are also captivated many of the large foodservice suppliers like Mcdonald's KFC Panda Express et cetera, and those channels are opening up consumers to new plant based protein offerings and we just feel very good about the long term.
<unk> growth prospects and with what were the.
The engagements, we have with customers right now.
But that was what I was referring to earlier was just those ups and downs, primarily in alternative meats related to the impact of retail vis vis foodservice.
And just maybe to drill down again.
Do you have a sense of what a normal margin structure in this pea protein business should be or what it is right now for your competitors I mean your competitors are doing it so.
Is it fair to say that you have a good sense of what they're earning and and that gives you more confidence that once you get up to speed that you can get there like have you done good benchmarking work to to really know what the margins are.
Well certainly when we justified the investment in Pea protein isolate.
Looked at the overall.
Demand projections as well as the supply projections and the unique attributes that <unk> has vis vis wheat and soy and so.
When you think about.
Alternative meats or plant based meats.
Occupying a very very small percentage, maybe 2% or less of the market at large today and the ability to grow to four 6% going forward that just represents a tremendous amount of demand versus existing supply and so we've modeled all of that out as it relates to the value proposition.
Working with our customers and we feel very good about what that all means from a standpoint of the margins for this business and we see a deficit going forward here over the next certainly five years with all of our models in relationship to demand outstripping supply and what that means for pricing and margins.
Okay I'll, let it go thank you.
Our next question comes from Ben Bienvenu with Stephens.
Hey, Thanks, good morning, guys.
Yes.
I wanted to follow up.
The plant based protein question from Rob there.
With respect to when you think about south Sioux City, and Vanscoy ramping up to full capacity, what sort of runway does that give you to achieve.
Youre capture of the secular growth in the categories that you've underwritten and when do you start to think about potentially adding incremental capacity and what's the organizational bandwidth to make additional plant capacity investments.
Yeah, It's one of the questions that our board asks me all the time. So it's a very good question a strategic question because.
We and our board are looking past this short term.
<unk>.
Given what I was just talking about in relationship to the long term drivers and growth prospects for plant based proteins and so this facility is sizable this facility gives us a very nice foothold in the plant based protein space.
And we think we think it serves us extremely well, we're very focused obviously right now on the execution of that and get into delivery and the returns on this investment.
But we are already thinking about what our options could be as far as being able to expand that capacity.
But also and I talked about this previously we're not just focused exclusively on Pea protein. We think it is very wise and prudent to look at alternative sources of protein.
From a standpoint of the total nutritional density as well as the functionality attributes that youre going to need to provide not just for alternative meat, but for alternative dairy et cetera. So as far as what you can expect to hear from us going forward.
With additional perhaps investments in the plant based protein space it'll be thought through very strategically based on a functional complement of plant based proteins to deliver on all the necessary attributes you need to have to deliver on taste functionality texture et cetera.
Okay. Thank you Tim.
Jim Great revisiting the question around <unk>.
<unk> in the guidance from top and bottom end.
Can you talk a little bit about which buckets you feel like you have most versus least visibility into.
And I think if we rewind to this time last year.
Guys various greatly of hedged your gross corn costs through the first half of 2021.
Would the same be true this year and Youre more open in the back half of 2022.
I think you guys are hedged on natural gas, but could we revisit where you stand there and then on freight.
When do you.
How much is spot versus contracted and when do you renegotiate those prices. Thank you.
Sure.
I think Ben as we think.
About the kind of the certainty of our cost structure as we're looking into 2022 with regard to corn hedging and.
Even co products, we're really looking at new at our hedging practices and trying to be able to extend.
Our hedges, even further not just into the year, but really get at the value at risk. It will have more to talk about there, but clearly it's something that I think is even a further opportunity to reduce.
Profit volatility both in our core business and our specialty business.
And we are sufficiently hedged within North America through even I would say even into the third quarter and into the fourth quarter.
With regard to natural gas.
Place most of our natural gas hedges in the year. Prior so we're largely <unk>.
<unk>, plus 90% plus covered on natural gas.
Where are we where we need to buy that.
Would say that you are always subject to a little bit too.
Disruption.
We're watching Europe very closely we have operations in Homburg, Germany, Germany is quite dependent upon.
Energy sources from Russia, So that's at least on our radar.
And then I think with regard to freight.
Yes.
Mostly when we think we've talked a lot about the U S freight market.
We go out and will contract.
95% to 98% of our preferred lanes and carriers.
And we're in.
Multiple iterations of doing this and so when were talking about did the preferred carrier show up and do we have to use spot. We're talking about very very small changes 1234 points down versus the expected performance that our preferred carrier has been giving us.
At that particular facility.
Just that you are right. When you go from your preferred lane to your spot is going to be 30%, 40%, 50% more so to the extent that you have to do that or to the extent that you have to make up for a customer pick up youre going to be incurring freight, but we're very thoughtful very comprehensive on our freight coverage.
When we get disruptions with rail we get disruptions with.
A dry van carrier or you get elevated ocean freight.
So those things are going to be in the moment theyre going to show up in the financials.
We're working as a team to get those rates back down and we're also working with customers to share in that cost.
Okay. Thank you.
Sure.
Ladies and gentlemen, this does conclude the Q&A portion of today's conference I'd like to turn the call back to Jim <unk>, President and CEO for any closing remarks.
Yes.
Thank you for joining us. This morning, we look forward to a time when we can see you again in person.
Please note we are presenting virtually at the consumer analyst group of New York on February 23rd and hosting an Investor day on June 2nd which will be a combination of a virtual presentation and an in person tour at our Bridgewater Innovation Center until then thank you for your continued interest in ingredients.
Ladies and gentlemen, this does conclude today's presentation. You may now disconnect and have a wonderful day.
[music].
[music].
[music].